Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy

NCT03117946 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
220
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Hospitalier Universitaire de Besancon